1 Introduction 10
1.1 Industry Definition and Research Scope 10
1.1.1 Industry Definition 10
1.1.2 Research Scope 11
1.2 Research Methodology 14
1.2.1 Overview of Market Research Methodology 14
1.2.2 Market Assumption 15
1.2.3 Secondary Data 15
1.2.4 Primary Data 15
1.2.5 Data Filtration and Model Design 16
1.2.6 Market Size/Share Estimation 17
1.2.7 Research Limitations 18
1.3 Executive Summary 19
2 Market Overview and Dynamics 22
2.1 Market Size and Forecast 22
2.1.1 Impact of COVID-19 on World Economy 24
2.1.2 Impact of COVID-19 on the Market 27
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 29
2.2 Major Growth Drivers 33
2.3 Market Restraints and Challenges 39
2.4 Emerging Opportunities and Market Trends 42
2.5 Porter?s Fiver Forces Analysis 46
3 Segmentation of Global Market by Vaccine Type 50
3.1 Market Overview by Vaccine Type 50
3.2 Live/Attenuated Vaccines 52
3.3 Inactivated Vaccines 53
3.4 Subunit Vaccines 54
3.5 Toxoid Vaccines 55
3.6 Conjugate Vaccines 56
3.7 mRNA Vaccines 57
3.8 Recombinant Vector Vaccines 58
3.9 Other Vaccines 59
4 Segmentation of Global Market by Disease 60
4.1 Market Overview by Disease 60
4.2 Pneumococcal Disease 62
4.3 Poliovirus 63
4.4 Hepatitis 64
4.5 Influenza 65
4.6 Measles, Mumps, and Rubella (MMR) 66
4.7 Varicella 67
4.8 Human Papilloma Virus 68
4.9 COVID-19 69
4.10 Other Diseases 70
5 Segmentation of Global Market by Administration 71
5.1 Market Overview by Administration 71
5.2 Intramuscular Route 73
5.3 Subcutaneous Route 74
5.4 Oral Route 75
5.5 Intravenous Injection 76
5.6 Other Administration Routes 77
6 Segmentation of Global Market by Patient 78
6.1 Market Overview by Patient 78
6.2 Pediatric Vaccines 80
6.3 Adult Vaccines 82
7 Segmentation of Global Market by Region 84
7.1 Geographic Market Overview 2022-2032 84
7.2 North America Market 2022-2032 by Country 88
7.2.1 Overview of North America Market 88
7.2.2 U.S. 92
7.2.3 Canada 96
7.2.4 Mexico 99
7.3 European Market 2022-2032 by Country 102
7.3.1 Overview of European Market 102
7.3.2 Germany 106
7.3.3 U.K. 109
7.3.4 France 112
7.3.5 Spain 115
7.3.6 Italy 118
7.3.7 Russia 121
7.3.8 Rest of European Market 124
7.4 Asia-Pacific Market 2022-2032 by Country 126
7.4.1 Overview of Asia-Pacific Market 126
7.4.2 Japan 130
7.4.3 China 134
7.4.4 Australia 137
7.4.5 India 140
7.4.6 South Korea 143
7.4.7 Rest of APAC Region 146
7.5 South America Market 2022-2032 by Country 148
7.5.1 Argentina 151
7.5.2 Brazil 154
7.5.3 Chile 157
7.5.4 Rest of South America Market 160
7.6 MEA Market 2022-2032 by Country 161
7.6.1 UAE 164
7.6.2 Saudi Arabia 167
7.6.3 South Africa 170
7.6.4 Other National Markets 173
8 Competitive Landscape 174
8.1 Overview of Key Vendors 174
8.2 New Product Launch, Partnership, Investment, and M&A 177
8.3 Company Profiles 178
AstraZeneca plc 178
Bavarian Nordic A/S 180
China National Biotec Group Company Ltd. 183
CSL Ltd. 185
Daiichi Sankyo Co. Ltd 187
Emergent BioSolutions Inc. 189
GlaxoSmithKline plc 191
Johnson & Johnson 195
Merck & Co. 197
Moderna Inc. 199
Novavax, Inc. 200
Pfizer Inc. 202
Sanofi SA 206
Takeda Pharmaceutical Co. Ltd. 209
RELATED REPORTS 211